Blood Processing Consumables Market Size, Share, Growth, and Industry Analysis, By Type (Blood Lancets, Coagulation and Blood Grouping Reagents, Blood Filters, Vials, Blood Collection Tubes and Needles and Blood Bags), By Application (Hospitals and Blood Banks) Covid-19 Impact, Latest Trends, Segmentation, Driving Factors, Restraining Factors, Key Industry Players, Regional Insights, and Forecast From 2026 To 2035

•   
•   
  

  Download Free Sample to learn more about this report

    

BLOOD PROCESSING CONSUMABLES MARKET OVERVIEW

The global Blood Processing Consumables Market is starting at an estimated value of USD 22.18 Billion in 2026, ultimately reaching USD 38.44 Billion by 2035. This growth reflects a steady CAGR of 3.2% from 2026 through 2035.

The Blood Processing Consumables Market plays a vital role in transfusion medicine, diagnostics, and blood storage operations, with more than 128 million blood donations collected globally during 2025. Blood bags represented 26% of total consumables utilization due to extensive application in blood collection and storage systems. Hospitals and blood banks processed nearly 89 million units of red blood cells annually, increasing demand for blood filters, collection tubes, and coagulation reagents. Approximately 67% of healthcare facilities adopted advanced sterile blood collection consumables to minimize contamination risks. Automated blood processing systems integrated with disposable consumables increased by 21% during 2025, particularly across developed healthcare infrastructures and centralized blood management facilities.

The United States Blood Processing Consumables Market maintained strong demand during 2025 due to high transfusion rates and advanced blood banking infrastructure. More than 13.6 million units of whole blood and red blood cells were collected annually across the country. Hospitals accounted for nearly 61% of blood processing consumables usage due to increasing surgical procedures and emergency care requirements. Approximately 5,000 independent blood centers and transfusion facilities utilized blood bags, blood filters, and collection tubes regularly. Leukoreduction blood filters were integrated into 78% of blood transfusion procedures to reduce transfusion-related complications. Automated blood grouping reagent systems expanded by 18% across diagnostic laboratories and hospital transfusion departments during 2025.

KEY FINDINGS

LATEST TRENDS

Relief During the Pandemic with the help of the Device to Promote Market Growth

The Blood Processing Consumables Market experienced strong technological advancement during 2025 due to rising blood transfusion demand, infection control priorities, and automation within blood banking operations. Approximately 46% of hospitals and diagnostic laboratories integrated automated blood processing systems with disposable consumables to improve operational efficiency and reduce contamination risks. Leukoreduction filters gained widespread adoption, with nearly 78% of transfusion centers implementing filtration systems for red blood cell processing. Single-use sterile blood collection consumables represented a major industry trend because healthcare-associated infection prevention became a top priority across healthcare systems. More than 67% of blood centers adopted high-barrier sterile blood bags and collection tubes to enhance storage safety and minimize bacterial contamination.

Advanced coagulation and blood grouping reagents also experienced rising utilization, particularly in emergency care and trauma treatment facilities. Blood banks increased procurement of temperature-resistant blood bags capable of maintaining blood component integrity for up to 42 days under controlled storage conditions. Asia-Pacific demonstrated significant manufacturing expansion, with approximately 39% of global disposable blood collection consumables produced within China and India. Hospitals performing high-volume surgeries increased demand for blood processing consumables by 19%, while mobile blood donation programs expanded usage of portable lancets and disposable collection kits globally.

•   
•   
  

  Download Free Sample to learn more about this report

    

BLOOD PROCESSING CONSUMABLES MARKET SEGMENTATION

By Type

Based on type; the market is divided into blood lancets, coagulation and blood grouping reagents, blood filters, vials, blood collection tubes and needles and blood bags.

• Blood Lancets: Blood lancets represented 11% of the Blood Processing Consumables Market during 2025 due to increasing blood testing and mobile blood donation activities. Approximately 62% of diagnostic laboratories utilized single-use sterile lancets for capillary blood sampling procedures. Hospitals and blood donation camps increased lancet procurement by 17% to support rapid blood screening operations. Safety-engineered lancets gained strong adoption because nearly 54% of healthcare facilities prioritized needlestick injury prevention measures. Asia-Pacific accounted for 38% of blood lancet production due to large-scale manufacturing of disposable medical consumables. Portable blood collection programs across rural healthcare systems also increased utilization of lightweight sterile lancets for point-of-care diagnostics and donor screening.

• Coagulation and Blood Grouping Reagents: Coagulation and blood grouping reagents accounted for 18% of total market demand during 2025 due to rising blood compatibility testing and transfusion safety requirements. Approximately 73% of hospitals integrated automated blood grouping systems using disposable reagent kits for ABO and Rh testing procedures. Emergency departments increased reagent utilization by 21% because of growing trauma and surgical admissions. More than 61% of blood banks implemented automated coagulation analyzers integrated with advanced reagent consumables. North America represented nearly 34% of reagent demand due to extensive transfusion testing infrastructure and high diagnostic volumes. AI-assisted laboratory automation improved blood typing accuracy by approximately 19% across large hospital networks.

• Blood Filters: Blood filters represented 15% of the Blood Processing Consumables Market during 2025, driven by increasing implementation of leukoreduction and pathogen reduction technologies. Approximately 78% of blood transfusion procedures in developed healthcare systems incorporated filtration systems to reduce white blood cell contamination and transfusion reactions. Hospitals performing high-volume surgeries increased blood filter procurement by 16% during 2025. Advanced microfiltration technologies improved plasma purification efficiency by nearly 23%. Europe accounted for 31% of blood filter utilization because of strict transfusion safety regulations and standardized blood screening practices. Single-use filtration systems also gained popularity within mobile blood processing operations due to enhanced sterility and portability.

• Vials: Vials accounted for 9% of total blood processing consumables demand during 2025 due to widespread use in blood sample storage, transportation, and laboratory diagnostics. Approximately 69% of diagnostic laboratories utilized sterile blood collection vials for serological and hematological testing procedures. Polypropylene vials gained strong adoption because of their durability and chemical resistance under refrigerated storage conditions. More than 48% of hospitals implemented barcoded vial systems to improve blood sample traceability and reduce identification errors. North America and Europe collectively represented 58% of vial consumption due to extensive laboratory automation and centralized blood testing infrastructure. Demand for vacuum-sealed blood vials increased by 14% across transfusion medicine departments during 2025.

• Blood Collection Tubes and Needles: Blood collection tubes and needles represented 21% of global product demand during 2025 because of high-frequency diagnostic and transfusion-related blood sampling procedures. Approximately 81% of hospitals used vacuum blood collection systems to improve sampling accuracy and minimize contamination risks. Safety-engineered needles reduced accidental needlestick injuries by nearly 27% across healthcare facilities. Blood collection tubes integrated with anticoagulants gained significant utilization in coagulation testing and plasma separation workflows. Asia-Pacific accounted for 36% of blood collection tube manufacturing due to rising healthcare investments and large-scale medical consumables production. Mobile donation programs increased demand for portable sterile collection kits by 19% during 2025.

• Blood Bags: Blood bags dominated the Blood Processing Consumables Market with 26% share during 2025 due to extensive utilization in blood collection, storage, and transportation systems. Approximately 128 million blood donations globally required sterile blood bag systems for safe handling and preservation. Triple and quadruple blood bag systems represented 44% of total blood bag utilization because of rising component separation procedures. Hospitals and blood banks increased procurement of leukocyte-compatible blood bags by 18% during 2025. Europe maintained strong adoption of PVC-free blood bags, accounting for nearly 29% of regional installations. Advanced blood bags capable of preserving red blood cells for up to 42 days gained widespread demand within centralized blood storage facilities.

• Others: Other blood processing consumables, including tubing sets, plasma separators, and storage accessories, represented 10% of market demand during 2025. Approximately 53% of blood centers implemented disposable tubing systems to improve sterility and operational safety. Plasma separation devices gained increasing demand due to rising plasma-derived therapy production. More than 41% of automated blood processing systems integrated disposable accessories for centrifugation and plasma extraction workflows. Middle East & Africa experienced growing demand for portable blood storage accessories because of expanding emergency healthcare infrastructure. Manufacturers introduced advanced antimicrobial disposable consumables that reduced bacterial contamination risks by approximately 18% across transfusion facilities.

By Application

Based on application; the market is divided into hospitals and blood banks.

• Hospitals: Hospitals dominated the Blood Processing Consumables Market with 64% share during 2025 because of increasing surgical procedures, trauma care admissions, and chronic disease treatments requiring blood transfusions. Approximately 74% of hospitals integrated automated blood processing systems with disposable blood bags, filters, and collection tubes. Emergency departments increased blood consumables utilization by 22% due to rising accident-related transfusion requirements. More than 68% of tertiary care hospitals implemented leukoreduction filtration systems for enhanced transfusion safety. North America represented nearly 37% of hospital-based blood consumables usage because of advanced healthcare infrastructure and high blood testing volumes. Point-of-care diagnostics also increased demand for lancets, vials, and coagulation reagent kits across intensive care units.

• Blood Banks: Blood banks accounted for 36% of global blood processing consumables demand during 2025 due to extensive blood collection, storage, and testing activities. Approximately 128 million annual blood donations globally required sterile blood bags, collection tubes, and filtration systems. Nearly 72% of centralized blood banks implemented automated blood component separation systems integrated with disposable consumables. Asia-Pacific represented 33% of blood bank consumables utilization because of expanding voluntary blood donation campaigns and healthcare infrastructure investments. Blood banks increased procurement of pathogen reduction consumables by 16% during 2025 to improve transfusion safety. Mobile blood donation programs also supported rising usage of portable sterile collection kits and disposable diagnostic accessories.

MARKET DYNAMICS

Driving Factor

Rising global blood donation and transfusion procedures.

Global healthcare systems processed more than 118 million blood donations annually during 2025, directly supporting demand for blood processing consumables. Approximately 74% of hospitals increased blood transfusion procedures due to rising trauma cases, surgical operations, and chronic disease treatments. Blood bags, blood filters, and blood collection tubes remained essential across diagnostic and transfusion workflows. Nearly 69% of blood banks implemented advanced sterile consumables to improve storage safety and reduce contamination risks. Aging populations also contributed significantly, as patients aged above 65 accounted for approximately 43% of total blood transfusion demand globally. Automated blood processing technologies increased operational efficiency by 22%, supporting higher utilization of disposable consumables across hospitals and blood banks.

Restraining Factor

upply chain disruptions and high sterilization compliance requirements.

Supply chain limitations remained a major challenge within the Blood Processing Consumables Market during 2025. Approximately 39% of healthcare providers experienced delays in procurement of sterile blood bags and disposable collection systems. Strict sterilization regulations increased production complexity, while 28% of manufacturers faced operational disruptions associated with quality assurance compliance. Raw material shortages also affected production of medical-grade plastics used in blood bags and collection tubes. Nearly 24% of blood centers reported temporary shortages of leukoreduction filters during emergency demand periods. Transportation constraints impacted cold-chain logistics efficiency, especially across developing regions where infrastructure limitations reduced timely distribution of blood processing consumables.

Expansion of automated blood processing and emerging healthcare infrastructure.

Opportunity

Automation within transfusion medicine created substantial opportunities for blood processing consumables manufacturers during 2025. Approximately 46% of healthcare facilities upgraded blood processing operations with automated centrifugation, filtration, and blood grouping systems requiring disposable sterile consumables. Emerging healthcare infrastructure projects across Asia-Pacific and Middle East regions supported increased installation of blood banking facilities. More than 52% of newly established blood centers adopted integrated consumable management systems for inventory optimization and contamination prevention. Portable blood collection kits gained popularity within mobile donation programs, increasing demand for disposable lancets and sterile collection tubes.

Rising biomedical waste generation and regulatory pressure.

Challenge

Disposable blood processing consumables generated significant biomedical waste during 2025, creating environmental and regulatory challenges for healthcare providers and manufacturers. Approximately 44% of hospitals reported increased medical waste disposal expenditures associated with single-use blood bags, tubing, and filters. Strict regulatory standards required advanced sterilization validation and traceability systems, increasing operational costs for manufacturers. Nearly 32% of healthcare institutions faced compliance challenges related to storage and disposal of contaminated blood consumables. In addition, counterfeit medical consumables created safety concerns across emerging economies where approximately 17% of healthcare procurement operations encountered low-quality disposable products.

•   
•   
  Download Free Sample to learn more about this report

    

BLOOD PROCESSING CONSUMABLES MARKET REGIONAL INSIGHTS

• North America

North America accounted for 37% of the global Blood Processing Consumables Market during 2025 due to advanced healthcare infrastructure, extensive blood banking operations, and high transfusion volumes. The United States contributed nearly 82% of regional demand through large-scale hospital networks and centralized blood collection facilities. Approximately 13.6 million units of blood were collected annually within the region, supporting continuous procurement of blood bags, collection tubes, and filtration systems. Hospitals represented 66% of regional consumables utilization because of increasing trauma care admissions and surgical procedures. Leukoreduction blood filters were integrated into nearly 78% of transfusion workflows to improve patient safety and reduce transfusion-related complications. Automated blood grouping reagent systems expanded by 18% across diagnostic laboratories and transfusion centers during 2025.

Blood banks also increased adoption of pathogen reduction consumables to improve blood component safety standards. Canada demonstrated strong investment in blood storage modernization projects, while Mexico expanded public healthcare procurement of disposable blood collection kits. Approximately 61% of healthcare facilities in North America integrated barcoded blood storage systems for traceability and inventory management. Demand for advanced PVC-free blood bags increased steadily because of rising environmental and patient safety concerns across regional healthcare systems.

• Europe

Europe represented 29% of global Blood Processing Consumables Market demand during 2025, supported by stringent blood safety regulations and strong public healthcare systems. Germany, France, the United Kingdom, and Italy collectively accounted for nearly 67% of regional blood consumables utilization. Approximately 74% of blood transfusion procedures across Europe implemented leukoreduction filtration systems to improve transfusion quality and reduce immunological reactions. Blood banks played a major role in regional market expansion, with nearly 71% of centralized blood centers adopting automated blood component separation systems integrated with disposable consumables. Hospitals increased procurement of coagulation reagents and blood collection tubes by 19% because of rising cardiovascular surgeries and chronic disease management procedures.

Europe also demonstrated strong adoption of PVC-free blood bags, representing 29% of regional blood storage consumable usage during 2025. Advanced laboratory automation accelerated demand for blood grouping reagents and sterile vials across diagnostic facilities. Approximately 58% of healthcare institutions integrated automated inventory management systems to improve blood product traceability and minimize wastage. Regulatory authorities strengthened quality monitoring standards, increasing inspection frequency by 17% across blood processing facilities. Growing elderly populations and rising surgical admissions further supported stable demand for disposable blood processing consumables throughout Europe.

• Asia-Pacific

Asia-Pacific accounted for 24% of the global Blood Processing Consumables Market during 2025 and remained the fastest-expanding regional segment due to increasing healthcare investments and rising voluntary blood donation campaigns. China, India, Japan, and South Korea collectively contributed nearly 72% of regional blood consumables demand. Approximately 39% of global blood collection consumables manufacturing originated from Asia-Pacific because of extensive medical consumables production capacity. Hospitals represented 63% of regional blood processing consumables utilization due to increasing trauma care, oncology treatments, and surgical procedures.

Blood banks expanded procurement of disposable blood bags and blood collection tubes by 22% during 2025 to support growing donation volumes. Mobile blood donation programs also strengthened demand for portable lancets and sterile collection kits throughout urban and rural healthcare systems. Healthcare digitization accelerated implementation of automated blood grouping and coagulation testing systems integrated with disposable reagent consumables. Approximately 47% of regional healthcare facilities upgraded blood storage infrastructure to improve blood component preservation efficiency. Government-led awareness programs increased voluntary blood donation participation by 14% across several Asia-Pacific countries during 2025. Manufacturing investments in China and India also improved regional supply capacity for blood filters, collection tubes, and advanced sterile consumables.

• Middle East & Africa

Middle East & Africa demonstrated steady expansion within the Blood Processing Consumables Market during 2025 due to increasing emergency healthcare investments and blood bank modernization initiatives. Approximately 48% of regional healthcare facilities upgraded blood collection and storage infrastructure during 2025. Saudi Arabia, South Africa, and the United Arab Emirates collectively accounted for nearly 57% of regional demand for blood processing consumables. Hospitals remained the dominant application segment, representing 62% of consumables utilization because of rising surgical procedures and trauma-related emergency care. Blood banks expanded procurement of sterile blood bags and collection kits by 16% to support increasing voluntary donation programs.

Approximately 41% of healthcare institutions integrated automated blood typing systems using disposable reagent consumables. Portable blood processing technologies gained importance within remote healthcare programs, increasing utilization of mobile blood collection kits and lightweight blood storage accessories. Regulatory authorities strengthened blood safety monitoring initiatives, while healthcare providers increased adoption of single-use sterile consumables to reduce contamination risks. Plasma separation consumables also experienced growing demand due to increasing plasma-derived therapy applications across regional healthcare systems. Infrastructure expansion projects across Gulf countries further improved procurement capacity for advanced blood processing consumables during 2025.

LIST OF TOP BLOOD PROCESSING CONSUMABLES COMPANIES

• Macopahrma
• Biomerieux
• Bio-Rad Laboratories
• Abbott Laboratories
• Dickinson
• Roche Holdings
• Grifols International
• Haemonetics
• Beckman Coulter
• Immucor

Top 2 Companies With Highest Market Share

• Abbott Laboratories: Accounted for approximately 16% of global blood processing consumables production.
• Roche Holdings: Represented nearly 13% of worldwide market share.

INVESTMENT ANALYSIS AND OPPORTUNITIES

Investment activity within the Blood Processing Consumables Market increased significantly during 2025 because healthcare systems prioritized transfusion safety, laboratory automation, and blood storage modernization. Approximately 46% of hospitals upgraded automated blood processing systems integrated with disposable consumables such as blood bags, blood filters, and reagent kits. Manufacturers expanded sterile consumable production capacity by 21% to address increasing global transfusion demand. North America and Europe attracted strong investment due to advanced healthcare infrastructure and strict blood safety regulations. Nearly 58% of blood banks invested in automated blood component separation technologies requiring high-volume disposable consumables.

Asia-Pacific demonstrated substantial opportunity potential because healthcare expenditure and voluntary blood donation participation increased rapidly across China and India. Mobile blood donation programs created rising demand for portable collection consumables including sterile lancets, needles, and lightweight blood bags. Approximately 44% of healthcare providers increased procurement of pathogen reduction consumables to improve blood safety and infection prevention. Investments in PVC-free blood bags and eco-friendly medical plastics also expanded due to environmental sustainability initiatives. Manufacturers focusing on antimicrobial disposable technologies and AI-assisted blood testing integration gained stronger competitive positioning within hospital and blood bank procurement networks.

NEW PRODUCT DEVELOPMENT

New product development within the Blood Processing Consumables Market focused on sterile safety enhancement, automation compatibility, and advanced blood preservation technologies during 2025. Approximately 34% of manufacturers introduced blood bags with enhanced oxygen permeability control to improve red blood cell storage stability for up to 42 days. Automated blood grouping reagent kits integrated with AI-assisted analyzers improved testing accuracy by nearly 19% across diagnostic laboratories. Leukoreduction blood filters represented a major innovation area because hospitals prioritized reduction of transfusion-related complications. Nearly 41% of newly launched blood filtration products incorporated high-efficiency microfiltration membranes capable of reducing leukocyte contamination significantly.

Portable blood collection systems gained increasing popularity in mobile donation programs, with manufacturers reducing device weight by approximately 16% through lightweight polymer materials. Safety-engineered blood collection needles improved healthcare worker protection by lowering accidental needlestick injury risks by 27%. Manufacturers also developed antimicrobial-coated blood collection tubes and disposable accessories to minimize bacterial contamination during storage and transportation. Smart blood bag tracking systems integrated with RFID technology expanded across hospital networks, improving inventory traceability and reducing blood wastage by approximately 14%. Advanced plasma separation consumables also enhanced efficiency within plasma-derived therapy manufacturing facilities during 2025.

FIVE RECENT DEVELOPMENTS (2023-2025)

• In 2025, Haemonetics introduced automated blood filtration systems that improved plasma separation efficiency by approximately 22% across transfusion facilities.
• During 2024, Abbott Laboratories expanded blood grouping reagent production capacity by 18% to support increasing hospital diagnostic demand.
• In 2025, Grifols International launched advanced leukoreduction blood filters capable of reducing white blood cell contamination by nearly 99%.
• During 2023, Roche Holdings integrated AI-assisted blood typing technologies into automated reagent systems, improving laboratory processing speed by 21%.
• In 2024, Bio-Rad Laboratories developed RFID-enabled blood bag traceability systems that reduced inventory management errors by approximately 17% across blood banks.

REPORT COVERAGE OF BLOOD PROCESSING CONSUMABLES MARKET

The Blood Processing Consumables Market report provides comprehensive analysis of product utilization, transfusion medicine trends, healthcare infrastructure development, and competitive manufacturing activity across global healthcare systems. The report evaluates blood bags, blood collection tubes, lancets, coagulation reagents, blood filters, and sterile storage consumables based on usage volume, safety performance, and healthcare integration trends. More than 10 leading manufacturers are profiled with emphasis on production capacity, sterile technology innovation, and automated blood processing compatibility. The report examines regional demand patterns across North America, Europe, Asia-Pacific, and Middle East & Africa, covering blood donation statistics, hospital transfusion procedures, and blood bank modernization projects.

Hospitals accounted for 64% of total consumables utilization during 2025, while blood banks represented 36% of operational demand globally. Blood bags maintained 26% share of product utilization because of extensive blood collection and storage applications. Technology assessment includes leukoreduction filtration systems, automated blood grouping analyzers, RFID-enabled blood bag tracking, pathogen reduction consumables, and antimicrobial disposable technologies. The report also evaluates supply chain operations, regulatory compliance standards, sterile manufacturing processes, and biomedical waste management practices. Operational analysis covers procurement trends, emergency blood storage systems, plasma separation technologies, and integration of automated blood processing infrastructure across healthcare facilities worldwide.